Literature DB >> 8182056

Human NAD(P)H:quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression.

A K Jaiswal1.   

Abstract

Human NAD(P)H:quinone oxidoreductase2 (NQO2) gene, 1336 base pairs (bp) of the 5'-flanking region and 165 bp of the 3'-flanking region, have been sequenced. NQO2 gene is 20 kilobase pairs in length and have seven exons interrupted by six introns as compared to the previously cloned NQO1 gene which contains six exons. 187 bp of the first exon in the NQO2 gene are noncoding and are absent in the NQO1 gene. 92 bp of the second exon in the NQO2 gene corresponded to the first exon of the NQO1 gene and so on. The sizes and nucleotide sequences of exons 3-6 are highly conserved between NQO2 and NQO1 genes. The last exon in the NQO2 gene is 1603 bp shorter than the last exon of the NQO1 gene and encodes for 58 amino acids as compared to 101 amino acids encoded by the NQO1 gene. This makes NQO2 protein 43 amino acids shorter than the NQO1 protein. The high degree of conservation between NQO2 and NQO1 gene organization and sequence confirmed that NQO2 gene encodes for a second member of the NQO gene family in human. Nucleotide sequence analysis of the 5'-flanking region of the NQO2 gene revealed presence of four SP1 binding sites at positions -214, -170, -106, and -75, a single copy of the antioxidant response element (ARE) at nucleotide -936, and three copies of xenobiotic response element (XRE) at positions -708, -557, and -51. ARE and XRE elements have previously been found in the promoters of the NQO1 and glutathione S-transferase Ya subunit genes and mediate increases in their expression in response to polycyclic aromatic compounds, phenolic antioxidants, and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), respectively. The NQO2 cDNA-derived protein in monkey kidney COS1 cells efficiently catalyzed nitroreduction of anti-tumor compound CB10-200, an analog of nitrophenylaziridine. Northern blot analysis indicates that NQO2 gene is expressed in human heart, brain, lung, liver, and skeletal muscle but does not express in placenta. In contrast, the NQO1 gene was expressed in all human tissues. Large variations were noticed for expression of the NQO2 and NQO1 genes among various tissues, 1336 bp of the 5'-flanking region of the NQO2 gene containing ARE and XRE was found sufficient to increase expression of the CAT gene in response to beta-naphthoflavone and tCDD in transfected human hepatoblastoma (Hep-G2) cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182056

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.

Authors:  Arup Maiti; P V Narasimha Reddy; Megan Sturdy; Laura Marler; Scott D Pegan; Andrew D Mesecar; John M Pezzuto; Mark Cushman
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

Review 2.  Enzymology of bioreductive drug activation.

Authors:  D Ross; H D Beall; D Siegel; R D Traver; D L Gustafson
Journal:  Br J Cancer Suppl       Date:  1996-07

3.  Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.

Authors:  R Venugopal; A K Jaiswal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase)

Authors:  Q Zhao; X L Yang; W D Holtzclaw; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  Genetic association of NQO1 609C>T polymorphism with risk of gastrointestinal cancer: evidence from case-control studies.

Authors:  Haixia Liu; Sixin Zhou; Lin Ma; Jun Yang; Hao Yang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential.

Authors:  M B Kumar; G H Perdew
Journal:  Gene Expr       Date:  1999

7.  Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor.

Authors:  Masahiro Nomoto; Masaaki Miyata; Shanai Yin; Yasushi Kurata; Miki Shimada; Kouichi Yoshinari; Frank J Gonzalez; Kokichi Suzuki; Shigeki Shibasaki; Tohru Kurosawa; Yasushi Yamazoe
Journal:  Biol Pharm Bull       Date:  2009-02       Impact factor: 2.233

8.  Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells.

Authors:  V Krishnan; W Porter; M Santostefano; X Wang; S Safe
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

9.  The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.

Authors:  R Li; M A Bianchet; P Talalay; L M Amzel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

Review 10.  Azoreductases in drug metabolism.

Authors:  Ali Ryan
Journal:  Br J Pharmacol       Date:  2016-09-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.